An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison images, administration instructions and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.
Some experts said the demand for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to the social media company, the platform has taken down violative content and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at home.
After minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Pricing
Inside these communities, posts show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her team has already encountered individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.
